You are here

Article Text

Article menu
Poster walk sessions
Neonatal metabolic II
TRANSCUTANEOUS BILIRUBIN NOMOGRAM FOR HEALTHY TERM AND NEAR-TERM NEONATES
  1. S Fouzas1,
  2. D Bougioukou1,
  3. A Varvarigou1,
  4. S Mantagos1
  1. 1Department of Pediatrics, School of Medicine, University of Patras, Patras, Greece

Abstract

Background and Aims Determination of transcutaneous bilirubin (TcB) represents a reliable non-invasive method for assessing neonatal bilirubinaemia. The aim of our study was to develop an hour-specific TcB nomogram for term and near-term neonates.

Methods Serial TcB measurements (Bilicheck bilirubinometer) were performed at designated times during the first 96 h of life, in healthy neonates (gestational age >35 weeks and birth weight >2000 g), from September 2005 to August 2007. The 5th, 25th, 50th, 75th and 95th percentiles of TcB measurements were calculated and plotted on an hour-specific nomogram.

Results In total, 8195 TcB measurements were performed in 1685 newborn infants. Ninety (5.4%) neonates developed serious hyperbilirubinaemia and underwent phototherapy. The hour-specific TcB nomogram is presented in the fig.

Conclusions TcB levels in healthy newborn infants increased according to a particular pattern during the first 96 h of life. We present an hour-specific TcB nomogram for healthy term and near-term neonates.

Figure 1
Figure 1

Fouzas et al

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.